Assessment of MRI Tractography for Pelvic Floor Sphincter Analysis (TractoCA)

March 28, 2022 updated by: IHU Strasbourg

Urinary and faecal incontinences generally come from a dysfunction of the pelvic floor muscles, and more particularly the sphincters. Among other causes, they may be related to accidental trauma, obstetric or iatrogenic. On this last point, the incidence of surgical interventions on the bladder collar and on the anal canal on the prevalence of incontinences can be underlined.

MRI tractography could be an interesting tool to visualize in 3D the structure of pelvic sphincters and their lesions. It may thereby establish the link with observed dysfunctions, thus potentially providing a complement to the urological and proctographic examinations already carried out.

The objective of this study is, first, to define the sensitivity of the MRI tractography for the visualization of the pelvic sphincters architecture regardless of the gender. In a second time, it will give a description of normal and abnormal (pathological cases) tractography, as well as a descriptive post-surgery. The other interest of this study is the assessment of the information provided by pelvic sphincters tractography on a panel of various and frequently encountered situations in clinical routine at the IHU.

Study Overview

Detailed Description

Urinary and faecal incontinences are psychologically difficult to live with. These disorders generally come from a dysfunction of the pelvic floor muscles, and more particularly the sphincters: the urethral sphincter at the level of the urinary tract, and the anal sphincter at the level of the defecatory apparatus. The causes leading to urinary or faecal incontinence are multiple. They may be related to age or weight, or to accidental trauma, obstetric or iatrogenic. On this last point, the incidence of surgical interventions on the bladder collar and on the anal canal on the prevalence of incontinences can be underlined.

In case of dysfunction, the sphincters can be scanned by imaging, including MRI, to assess the thickness or detect the presence of scars. The current MRI examinations in clinical routine are not capable to characterize the complex architecture of these muscles. MRI tractography, mainly known as a tool for visualisation and characterisation of white matter fibers in the brain via the acquisition of DTI (Diffusion Tensor Imaging) sequences, could be an interesting tool to visualize in 3D the structure of pelvic sphincters and their lesions. It may thereby establish the link with observed dysfunctions, thus potentially providing a complement to the urological and proctographic examinations already carried out.

Some studies have already shown that MRI is an ideal method for visualizing pelvic floor muscle fibers in women. As far as it is known, there are no studies in the literature on pelvic sphincter tractography. The objective is, first, to define from this initial study the sensitivity of the method for the visualization of the pelvic sphincters architecture regardless of the gender. In a second time, it will give a description of normal and abnormal (pathological cases) tractography, as well as a descriptive post-surgery. The results found in each of these situations can be compared in order to evaluate the sensitivity and contribution of MRI tractography for the diagnosis of pelvic sphincter dysfunctions and their management, as well as to evaluate the impact of surgery.

The other interest of this study is the inclusion of both patients consulting for a simple diagnosis and those coming for a pre- and post-operative examination. This will allow the assessment of the information provided by pelvic sphincters tractography on a panel of various and frequently encountered situations in clinical routine at the IHU.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Strasbourg, France, 67 091
        • Service de Radiologie et d'Echographie, NHC Strasbourg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Male or female over 18 years old
  2. Patient able to receive and understand information related to the study and give written informed consent
  3. Patient affiliated to the French social security system
  4. Patient undergoing a pelvic MRI examination whose result at the end of the T2 sequences in the 3 section planes shows the absence of pathology or a distant pathology that does not affect the pelvic sphincters OR Patient undergoing a pelvic surgery including fistula treatment, abscess treatment, sigmoid mucosectomy or rectal mucosectomy

Exclusion Criteria:

  1. Patient who previously had a therapeutic procedure affecting the sphincters
  2. Patient with hip prostheses
  3. Patient with contraindications to MRI:

    • pacemaker or automatic defibrillator, pump
    • implanted
    • auditory, anal, painkiller neurostimulator, etc ...
    • ferromagnetic bodies in soft tissues, body
    • intraocular foreigners, cerebrovascular clips
    • claustrophobia
  4. Patient presenting, in the judgment of the investigator, an illness that may prevent participation in the procedures provided by the study
  5. Pregnant or lactating patient
  6. Patient in exclusion period (determined by a previous or a current study)
  7. Patient under guardianship or trusteeship
  8. Patient under the protection of justice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Pelvic MRI

This arm involves patients undergoing a pelvic MRI.

At the end of the planned sequence, but before any contrast agent injection:

  • Acquisition of a an additional anatomical T2 SPACE sequence
  • Acquisition of a tractography Diffusion Tensor Imaging (DTI) sequence All acquisitions will be done in an acceptable duration (less than 45 minutes)

At the end of the planned sequence, but before any contrast agent injection:

  • Acquisition of a an additional anatomical T2 SPACE sequence
  • Acquisition of a tractography DTI sequence
EXPERIMENTAL: Pelvic surgery

This arm involves patients undergoing a pelvic surgery and coming for a postoperative MRI. An additional MRI is performed before the surgery and additional sequences are added to the planned postoperative MRI, at the end of the planned sequence, but before any contrast agent injection:

  • Acquisition of a an additional anatomical T2 SPACE sequence
  • Acquisition of a tractography Diffusion Tensor Imaging (DTI) sequence All acquisitions will be done in an acceptable duration (less than 45 minutes)

At the end of the planned sequence, but before any contrast agent injection:

  • Acquisition of a an additional anatomical T2 SPACE sequence
  • Acquisition of a tractography DTI sequence

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The ability of MRI tractography to visualize the muscular architecture of pelvic sphincters evaluated with a Likert score.
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group

This criterion is quantitative and is evaluated on the basis of a Likert score varying between 1 and 5 which will be attributed to each sphincter.

  • Score 1 = no reconstruction: sphincter not visualised
  • Score 2 = insufficient reconstruction: the fiber architecture is incoherent and / or few fibers are rebuilt
  • Score 3 = acceptable reconstruction: the reconstructed fibers provide an overview of sphincter architecture despite the presence of incoherent or missing fibers
  • Score 4 = satisfactory reconstruction: the sphincter is generally well reconstructed, little incoherence and missing fibers
  • Score 5 = excellent reconstruction: the appearance of the sphincter reflects the expected anatomy, without missing or inconsistent fibers.
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the sphincter orientation based on a color gradient.
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group

The reconstruction of the muscle fibers in tractography is done according to a precise color code (blue if orientation up-down, green for front-back, and red for left-right).

The analysis will be done on the color gradient.

1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
Thickness of the sphincters evaluated in millimetres
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
The thickness of the sphincters will be measured in millimetres
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
Fractional Anisotropy (FA) Values in Sphincter Fibres
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
Fractional anisotropy (FA) is a scalar value between zero and one that describes the degree of anisotropy of a diffusion process. A value of zero means that diffusion is isotropic, i.e. it is unrestricted (or equally restricted) in all directions. A value of one means that diffusion occurs only along one axis and is fully restricted along all other directions.
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
Apparent Diffusion Coefficient (ADC) Values in Sphincter Fibres
Time Frame: 1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group
Apparent diffusion coefficient (ADC) is a measure of the magnitude of diffusion (of water molecules) expressed in units of square millimetres per second (mm2/s).
1 day for the "Pelvic MRI" group - 2 months for the "Pelvic surgery" group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Catherine ROY, MD, Service de Radiologie et d'Echographie, NHC Strasbourg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 12, 2019

Primary Completion (ACTUAL)

August 12, 2021

Study Completion (ACTUAL)

August 12, 2021

Study Registration Dates

First Submitted

March 4, 2019

First Submitted That Met QC Criteria

March 18, 2019

First Posted (ACTUAL)

March 19, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 29, 2022

Last Update Submitted That Met QC Criteria

March 28, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Bowel Disease

Clinical Trials on MRI with DTI sequence

Subscribe